Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
0 competitors in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
View Full LandscapeTarget Indication
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Clinical Trial
NCT06081894Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Myqorzo
Treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adult patients.
View on EMAObstructive Hypertrophic Cardiomyopathy (oHCM)
Heart Failure With Reduced Ejection Fraction
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Heart Failure
Heart Failure